CV
Cadrenal Therapeutics, Inc. Common Stock
CVKD · NASDAQ
$1.19 -2.46% (-$0.03)
1M -38.66%
Market Cap $4.25M
P/E Ratio -
Div. Yield -
ROE 406.38%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 1.04x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 284.81%
ROE 406.38%
ROA 206.55%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 3.73x
Int. coverage N/A
Stability
42 /100
Moderate Beta 1.84x
EPS volatility 17.65%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CVKD
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Quang X. Pham
Employees
5
Headquarters
Ponte Vedra
Upcoming events
09 NOV
Earnings
Upcoming earnings report